China Life Private Equity Investment - aVenture Asset Manager Research
Location
Beijing, CN
Founded
2016
China Life Private Equity Investment, based in Beijing, focuses on equity investments in the financial services sector. The firm primarily targets Series B funding rounds, demonstrating a preference for companies with established traction and growth potential. Their investment strategy appears to encompass both domestic Chinese and international opportunities.
Notable in their portfolio is Metis Therapeutics, which has raised a total of $75 million. China Life Private Equity Investment leverages its position within the broader China Life Insurance Group to provide strategic value and industry connections to its portfolio companies. The firm's expertise in financial services and its ties to one of China's largest insurance companies offer unique advantages to startups in their network.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B1 (50.0%)
Series C1 (50.0%)
Stage Mix
Series B 50%Series C 50%
Concentration shown as share of disclosed investments by stage.
